Last updated on November 2017

Study Seeking Patients with Post Traumatic Stress Disorder (PTSD)


Brief description of study

Study Seeking Patients with Post Traumatic Stress Disorder (PTSD)

Detailed Study Description

A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole (1-3 mg/day) as Monotherapy or as Combination Therapy in the Treatment of Adults with Post-traumatic Stress Disorder

Clinical Study Identifier: TX10053

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Segal Institute for Clinical Research

Segal Institute for Clinical Research
North Miami, FL USA
  Connect »